1. Home
  2. VERX vs ADMA Comparison

VERX vs ADMA Comparison

Compare VERX & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertex Inc.

VERX

Vertex Inc.

HOLD

Current Price

$12.20

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$10.11

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERX
ADMA
Founded
1978
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
VERX
ADMA
Price
$12.20
$10.11
Analyst Decision
Buy
Buy
Analyst Count
15
4
Target Price
★ $17.15
$17.00
AVG Volume (30 Days)
1.2M
★ 2.6M
Earning Date
11-02-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.35
Revenue
★ $748,444,000.00
$42,219,783.00
Revenue This Year
$10.51
$4.93
Revenue Next Year
$10.51
$17.59
P/E Ratio
$302.25
★ $28.89
Revenue Growth
12.25
★ 43.85
52 Week Low
$10.21
$7.21
52 Week High
$26.54
$20.46

Technical Indicators

Market Signals
Indicator
VERX
ADMA
Relative Strength Index (RSI) 48.76 60.61
Support Level $12.16 $9.23
Resistance Level $13.56 $10.24
Average True Range (ATR) 0.49 0.42
MACD 0.05 0.08
Stochastic Oscillator 71.00 86.46

Price Performance

Historical Comparison
VERX
ADMA

About VERX Vertex Inc.

Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: